These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 8074453
61. The role of vitamin D in prostate cancer. Zhao XY, Feldman D. Steroids; 2001; 66(3-5):293-300. PubMed ID: 11179737 [Abstract] [Full Text] [Related]
62. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Schwartz GG, Hulka BS. Anticancer Res; 1990; 10(5A):1307-11. PubMed ID: 2241107 [Abstract] [Full Text] [Related]
63. Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs. van den Bemd GJ, Pols HA, van Leeuwen JP. Curr Pharm Des; 2000 May; 6(7):717-32. PubMed ID: 10828303 [Abstract] [Full Text] [Related]
64. Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)2D3 in prostate cancer cells in vitro. Shannan B, Seifert M, Boothman DA, Tilgen W, Reichrath J. J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):721-5. PubMed ID: 17224269 [Abstract] [Full Text] [Related]
70. Vitamin D and its analogs as anticancer and anti-inflammatory agents. Chen J, Tang Z, Slominski AT, Li W, Żmijewski MA, Liu Y, Chen J. Eur J Med Chem; 2020 Dec 01; 207():112738. PubMed ID: 32829183 [Abstract] [Full Text] [Related]
71. Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs. Eelen G, Gysemans C, Verlinden L, Vanoirbeek E, De Clercq P, Van Haver D, Mathieu C, Bouillon R, Verstuyf A. Curr Med Chem; 2007 Dec 01; 14(17):1893-910. PubMed ID: 17627525 [Abstract] [Full Text] [Related]
72. Vitamin D and prostate cancer. Feldman D, Zhao XY, Krishnan AV. Endocrinology; 2000 Jan 01; 141(1):5-9. PubMed ID: 10614617 [No Abstract] [Full Text] [Related]
73. Current progress in using vitamin D and its analogs for cancer prevention and treatment. Cheung FS, Lovicu FJ, Reichardt JK. Expert Rev Anticancer Ther; 2012 Jun 01; 12(6):811-37. PubMed ID: 22716497 [Abstract] [Full Text] [Related]
74. Will analogs of 1,25-dihydroxyvitamin D(3) (calcitriol) open a new era in cancer therapy? Reichrath J. Onkologie; 2001 Apr 01; 24(2):128-33. PubMed ID: 11441291 [Abstract] [Full Text] [Related]
75. The vitamin D Endocrine system: manipulation of structure-function relationships to provide opportunities for development of new cancer chemopreventive and immunosuppressive agents. Norman AW. J Cell Biochem Suppl; 1995 Apr 01; 22():218-25. PubMed ID: 8538201 [Abstract] [Full Text] [Related]
76. Mechanisms for the selective action of Vitamin D analogs. Bouillon R, Verlinden L, Eelen G, De Clercq P, Vandewalle M, Mathieu C, Verstuyf A. J Steroid Biochem Mol Biol; 2005 Oct 01; 97(1-2):21-30. PubMed ID: 16111885 [Abstract] [Full Text] [Related]
77. 20-Epi-vitamin D3 analogs. Potent modulators of proliferation and differentiation of breast cancer cell lines in vitro. Elstner E, Heber D, Koeffler HP. Adv Exp Med Biol; 1996 Oct 01; 399():53-70. PubMed ID: 8937548 [Abstract] [Full Text] [Related]
78. 1alpha,25-Dihydroxyvitamin D and fish oil synergistically inhibit G1/S-phase transition in prostate cancer cells. Istfan NW, Person KS, Holick MF, Chen TC. J Steroid Biochem Mol Biol; 2007 Mar 01; 103(3-5):726-30. PubMed ID: 17223546 [Abstract] [Full Text] [Related]
79. Vitamin D, vitamin D analogs (deltanoids) and prostate cancer. Brown WM. Expert Rev Clin Pharmacol; 2008 Nov 01; 1(6):803-13. PubMed ID: 24410609 [Abstract] [Full Text] [Related]
80. Novel vitamin d analogs for prostate cancer therapy. Chen TC, Kittaka A. ISRN Urol; 2011 Nov 01; 2011():301490. PubMed ID: 22084796 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]